98832290 - RETHINKDEPRESSION

Information

• Trademark
• 98832290

• Source

• Serial Number

  98832290

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 01, 2024
  a year ago

• Transaction Date

  April 15, 2025
  11 months ago

• Status Date

  April 10, 2025
  11 months ago

• Location Date

  April 10, 2025
  11 months ago

• Status Code

  692

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  BARREDA, AMBER

• Attorney Docket Number

  26657.104049

  Attorney Name

  Maren C. Perry

  Law Office Assigned Location Code

  L30

• Owners

  • H. Lundbeck A/S

Case File Statements

• GS0411: Education services, namely, arranging and conducting seminars, conferences, symposiums, workshops and courses in the field of medical research and development, science, clinical studies, tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational and training services in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing the aforementioned services electronically, on-line, via cable or Internet or other electronic media; arranging and conducting expert forums, including on-line in the form of seminars, conferences, symposiums, workshops and courses in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing on-line training programs in the field of research and development relating to the treatment and prevention of central nervous systems diseases and disorders, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing on-line publications, namely, books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development relating to the treatment and prevention of central nervous system diseases and disorders and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of online publications in the nature of books, reports, brochures, booklets, magazines, leaflets, journals, teaching and training materials in the fields of science, clinical trials and tests, diagnostics and medicine; arranging and conducting in-person and online educational expert forums in the fields of science, clinical trials and tests, diagnostics and medicine
• DM0000: The mark consists of the words "RETHINKDEPRESSION" with a thought cloud over the letter "I." The word "RETHINK" is in blue; the word "DEPRESSION" and the thought cloud are in red. The color white is not claimed as a feature of the mark and represents background.
• GS0051: Sanitary preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency on drugs, alcohol, nicotine and caffeine; diagnostic preparations, substances, reagents and agents for medical purposes
• PM0001: RETHINK DEPRESSION
• CC0000: The color(s) red and blue are claimed as a feature of the mark.
• GS0441: Medical services; medical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical consultancy relating to medical and pharmaceutical preparations; medical, clinical, therapeutic clinical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical and therapeutic services relating to the treatment and prevention of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; medical, clinical, therapeutic clinical services in the field of central nervous system stimulants, and for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of medical advice and medical information in the field of diagnostics, medicine, drugs, disorders, diseases, treatment and prevention; medical information service, namely, provision of medical information related to the medical dosage, diagnosis, therapeutic topics, medical administration, treatment and prevention of central nervous system disorders and diseases, and for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of online medical data and analytics designed to provide patients and clients with tailored information, on medical dosage, diagnoses, therapeutic topics and medical administration
• GS0421: Scientific and technological services, namely, research and design in the field of pharmaceuticals for the treatment and prevention of diseases and disorders of the central nervous system, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; industrial analysis and research in the field of research and development relating to the treatment and prevention of diseases and disorders of the central nervous system, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; providing online non-downloadable software for accessing data and information in the fields of research and development, science, clinical studies, trials and tests, diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; pharmaceutical research and development; scientific and technological services, namely, research and design in the field of disorders, diseases and prevention; scientific and technological services, namely, research and design in the field of central nervous system stimulants, pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases and drugs; medical and scientific research, namely, conducting clinical trials for others; clinical studies tests and trials; pharmaceutical research and development services; medical research; providing information in the field of research and development related to the treatment and prevention of central nervous system stimulants, and pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; provision of medical research information in the fields of research and development, science, clinical studies, trials and tests

Case File Event Statements

• 11/1/2024 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 11/18/2024 - a year ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 11/18/2024 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/5/2024 - a year ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/2/2024 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 12/5/2024 - a year ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/5/2024 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/4/2025 - a year ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/4/2025 - a year ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/1/2025 - a year ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/4/2025 - a year ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/10/2025 - 11 months ago

  12 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR